People · Operator
Named in public records as an officer, director or promoter · active 2008–2011 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gliamed Inc | — | Biotechnology | Seed | $2.5M | $109.5M | 2008 |
| Cardero Therapeutics, Inc. | — | Other | Pre-Seed | $1.9M | $20.6M | 2011 |
Barry Dickman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Barry Dickman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Weinstein | 1 | 3 |
| Andrew Busser | 1 | 2 |
| Alan Maisel | 1 | 1 |
| Sundeep Dugar | 1 | 1 |
| Andrew Uprichard | 1 | 1 |
| Julian Buckner | 1 | 1 |
| George Schreiner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.